Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/25/2025

Corticosteroid Tapering Guidelines

Introduction to Tapering

  • The decision to stop corticosteroid therapy mainly depends on the treatment duration, with a gradual tapering necessary after more than 3 weeks of treatment or doses above 7.5 mg prednisolone equivalent per day to prevent adrenal insufficiency 1, 2

When is Gradual Tapering Necessary?

  • For treatments lasting less than 3-4 weeks, even at high doses, abrupt cessation is possible without significant risk of adrenal insufficiency 1, 2
  • Gradual tapering is strongly indicated for any patient receiving more than 7.5 mg prednisolone equivalent per day for more than 3 weeks 1, 2
  • Initially, reduce the dose progressively until reaching a physiological dose (equivalent to 5 mg of prednisone or 15-20 mg of hydrocortisone per day) 2
  • For patients on chronic treatment at medium to high doses, reduce gradually (e.g., 0.5 mg/kg/month) 1

Disease-Specific Considerations

  • For autoimmune hepatitis, maintain fixed daily doses until therapeutic goals are achieved, and consider stopping after at least 2 years of treatment when liver tests and immunoglobulin levels are repeatedly normal 3
  • For bullous pemphigoid, continue maintenance treatment for 8 months (total duration including consolidation phase: 12 months), then stop 4
  • For severe alcoholic hepatitis, stop corticosteroid therapy in patients with a Lille score ≥0.56 (complete non-responders) 5

Monitoring for Adrenal Insufficiency

  • Measure morning cortisol to evaluate the recovery of adrenal function and guide the cessation of corticosteroids 2
  • Monitor symptoms of adrenal insufficiency: fatigue, weakness, orthostatic hypotension, weight loss, nausea 2

Risks of Abrupt Cessation

  • Abrupt cessation can precipitate a relapse or worsening of the underlying condition 1
  • In inflammatory bowel diseases, abrupt cessation of prednisone has been associated with disease flares 1

Special Situations Requiring Increased Caution

  • Patients with pre-existing adrenal insufficiency require a more cautious approach 2
  • Patients who have received multiple recent courses of steroids may have cumulative suppression and could benefit from a brief taper 2

Common Pitfalls to Avoid

  • A tapering period of at least 1 month is recommended after improvement of the condition 1
  • The tapering schedule should be planned with the advice of an organ specialist 1

Corticosteroid Therapy Discontinuation

Introduction to Discontinuation Guidelines

  • The American Gastroenterological Association recommends that for severe alcoholic hepatitis, prednisolone at a dose of 40 mg per day or methylprednisolone at a dose of 32 mg per day can be prescribed for 28 days, and at the end of treatment, it can be stopped abruptly or the dose can be tapered over a period of three weeks 6
  • The American Academy of Pediatrics suggests that in pediatric atopic dermatitis, short-term use (<7 days) of oral corticosteroids may be considered as needed clinically, although long-term use is not recommended 7
  • The American Society of Hematology panel determined that there is very low certainty evidence for the net benefit of longer courses of corticosteroids (>7 days) versus a shorter course in children with immune thrombocytopenia 8

Discontinuation and Tapering Considerations

  • The strength of evidence for the fact that reducing the dose of corticosteroids gradually after a short course is not necessary is based on low certainty evidence, however, the risk of adrenal insufficiency is minimal after 7 days of treatment 6
  • The guideline society recommends that for patients who receive more than 7.5 mg equivalent of prednisone per day for more than 3 weeks, tapering is strongly indicated to prevent adrenal insufficiency, however, this does not apply to short courses of 7 days or less 6